Alex Najibi

Alex Najibi is a driven scientist with extensive experience in preclinical research and immunotherapy. Currently serving as Scientist II at Kelonia Therapeutics, Alex previously held roles at ACIR as a freelance writer, generating public summaries of cancer immunotherapy research. Alex's academic background includes a Ph.D. in Bioengineering from Harvard University, where pivotal research focused on biomaterial-based vaccine technologies and collaborations with hospitals and biotech firms were conducted. Additionally, impactful undergraduate research was performed at the University of California, Berkeley, contributing to innovative projects involving microfluidics for HIV monitoring and cancer diagnosis. Alex's commitment to communication and education is demonstrated through previous positions as a resident assistant and consultant.